肝転移は、元々あった腫瘍やがんが肝臓に転移したものです。 肝転移は肝臓から始まるのではなく、他の患部から広がっていくものです。肝臓に転移したがんは、肝転移を引き起こします。肝転移治療は、肝転移を治すために用いられる方法です。肝臓に転移する一般的ながんには、乳がん、大腸がん、食道がん、肺がんなどがあります。乳がんや大腸がんの患者数の増加、がん治療に対する政府の支援や取り組みの増加、研究開発の活発化、対象疾患の罹患率の上昇などが、市場の成長を促進する要因となっています。
世界がん研究基金によると、2020年の世界の乳がんの症例数は約12.5%でしたが、肺がんの症例は同年で約12.2%でした。 2020年に190万件の新規症例が発生した結腸直腸がんは、すべてのがんの種類の中で 3 番目にランクされ、全症例の10.7%を占めました。さらに、世界保健機関は2040年までに乳がんによる250万人の死亡を防ぐという目標を達成するため、2023年2月に新たな世界乳がんイニシアチブの枠組みを発表しています。乳がんや大腸がんの症例が増加していること、政府の支援や取り組みが増加していることが、市場の成長を促進する大きな要因となっています。市場拡大を牽引するその他の重要な要素は、研究開発の進展と対象疾患の発生率の上昇です。肝転移症治療における技術的進歩や医療における研究開発の増加は、予測期間中に大きな市場機会を生み出しています。しかし、肝転移治療のコストが高いことが、2022年から2029年の予測期間を通じて市場の成長を阻害しています。
肝転移治療の世界市場の調査対象地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。北アメリカは、がんに対する先進的な治療法があること、がんに対する政府の政策が良好であること、アメリカなどの国では肝転移の有病率が高いことなどから、収益面で市場を支配しています。例えば、アメリカでは年間約14万件の肝転移症例があると言われています。アジア太平洋地域は、医療費の増加、医療施設へのアクセスの容易さ、効果的なスクリーニングの欠如などの要因から、予測期間中に最も高いCAGRで成長すると予想されます。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Liver Metastases Treatment Market, by Region, 2019-2029 (USD Billion)
1.2.2. Liver Metastases Treatment Market, by Type, 2019-2029 (USD Billion)
1.2.3. Liver Metastases Treatment Market, by Primary Cancer, 2019-2029 (USD Billion)
1.2.4. Liver Metastases Treatment Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Liver Metastases Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Liver Metastases Treatment Market Dynamics
3.1. Liver Metastases Treatment Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing cases of breast and colorectal cancer
3.1.1.2. Increasing government support and initiatives in cancer treatment
3.1.2. Market Challenges
3.1.2.1. High Cost of Liver Metastases Treatment
3.1.3. Market Opportunities
3.1.3.1. Technological advancements in Liver Metastases Treatment
3.1.3.2. Increasing R&D in healthcare
Chapter 4. Global Liver Metastases Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Liver Metastases Treatment Market, by Type
6.1. Market Snapshot
6.2. Global Liver Metastases Treatment Market by Type, Performance - Potential Analysis
6.3. Global Liver Metastases Treatment Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Liver Metastases Treatment Market, Sub Segment Analysis
6.4.1. Chemotherapy
6.4.2. Targeted Therapy
6.4.3. Immunotherapy
Chapter 7. Global Liver Metastases Treatment Market, by Primary Cancer
7.1. Market Snapshot
7.2. Global Liver Metastases Treatment Market by Primary Cancer, Performance - Potential Analysis
7.3. Global Liver Metastases Treatment Market Estimates & Forecasts by Primary Cancer 2019-2029 (USD Billion)
7.4. Liver Metastases Treatment Market, Sub Segment Analysis
7.4.1. Colorectal Cancer
7.4.2. Breast Cancer
Chapter 8. Global Liver Metastases Treatment Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Liver Metastases Treatment Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Liver Metastases Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Liver Metastases Treatment Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Specialty Pharmacies
Chapter 9. Global Liver Metastases Treatment Market, Regional Analysis
9.1. Liver Metastases Treatment Market, Regional Market Snapshot
9.2. North America Liver Metastases Treatment Market
9.2.1. U.S. Liver Metastases Treatment Market
9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Primary Cancer breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Liver Metastases Treatment Market
9.3. Europe Liver Metastases Treatment Market Snapshot
9.3.1. U.K. Liver Metastases Treatment Market
9.3.2. Germany Liver Metastases Treatment Market
9.3.3. France Liver Metastases Treatment Market
9.3.4. Spain Liver Metastases Treatment Market
9.3.5. Italy Liver Metastases Treatment Market
9.3.6. Rest of Europe Liver Metastases Treatment Market
9.4. Asia-Pacific Liver Metastases Treatment Market Snapshot
9.4.1. China Liver Metastases Treatment Market
9.4.2. India Liver Metastases Treatment Market
9.4.3. Japan Liver Metastases Treatment Market
9.4.4. Australia Liver Metastases Treatment Market
9.4.5. South Korea Liver Metastases Treatment Market
9.4.6. Rest of Asia Pacific Liver Metastases Treatment Market
9.5. Latin America Liver Metastases Treatment Market Snapshot
9.5.1. Brazil Liver Metastases Treatment Market
9.5.2. Mexico Liver Metastases Treatment Market
9.6. Rest of The World Liver Metastases Treatment Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. F. Hoffmann - La Roche Ltd.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. AstraZeneca
10.2.3. Bayer AG
10.2.4. Eli Lilly and Company
10.2.5. Ono Pharmaceutical
10.2.6. Pfizer, Inc.
10.2.7. Bristol - Myers Squibb Company
10.2.8. Cadila Pharmaceuticals Ltd.
10.2.9. Biocare Medical, LLC
10.2.10. Foundation Medicine, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
List of Tables
TABLE 1. Global Liver Metastases Treatment Market, report scope
TABLE 2. Global Liver Metastases Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Liver Metastases Treatment Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 4. Global Liver Metastases Treatment Market estimates & forecasts by Primary Cancer 2019-2029 (USD Billion)
TABLE 5. Global Liver Metastases Treatment Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 6. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Liver Metastases Treatment Market
TABLE 71. List of primary sources, used in the study of global Liver Metastases Treatment Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Liver Metastases Treatment Market, research methodology
FIG 2. Global Liver Metastases Treatment Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Liver Metastases Treatment Market, key trends 2021
FIG 5. Global Liver Metastases Treatment Market, growth prospects 2022-2029
FIG 6. Global Liver Metastases Treatment Market, porters 5 force model
FIG 7. Global Liver Metastases Treatment Market, pest analysis
FIG 8. Global Liver Metastases Treatment Market, value chain analysis
FIG 9. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Liver Metastases Treatment Market, regional snapshot 2019 & 2029
FIG 15. North America Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
FIG 16. Europe Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
FIG 19. Global Liver Metastases Treatment Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
